PUBLIC COMPANY
saveVedanta Biosciences Inc
updated 2mo ago
community read0 votes
pipeline
1
marketed
0
phase 3
1
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Phase 3
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →🐶 Hiring Signal
News
- ‘Significant’ demand for Revolution drug; Intellia pinpoints liver toxicity culpritEarly indicators from a compassionate use plan led analysts to hike projections for daraxonrasib. Elsewhere, Intellia believes it’s answered a key safety question and Arrowhead moved to catch a rival.biopharma_dive · 1mo ago
- Vedanta gets $60M to finish Phase 3 for C. diff microbiome therapyInvestors are pumping more money into one of the microbiome field's longest-standing biotechs to push it toward a Phase 3 readout in C. difficile next year. Cambridge, MA-based Vedanta Biosciences…endpoints · 1mo ago
- Fierce Biotech Layoff Tracker 2026: Enanta sheds staffers; BMS slashes 265 HQ rolesAs always, if you know of layoffs occurring at a biotech, please reach out to the Fierce Biotech editorial team.fiercebiotech · 9mo ago
comments(0)
5-min edit window · permanent after that